When treatment remains the best option: rechallenge with immune-checkpoint inhibitors driven by oncological benefit

19 June 2026 (12:36 - 12:45)
Organised by: Logo
Congress Presentation Part of: Immune checkpoint inhibitors and the many faces of cardiac injury: from myocarditis to coronary and conduction disease Cardio-Oncology Delegates Premium Access ESC Cardio-Oncology 2026 Council of Cardio-Oncology